The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 26, 2021

Filed:

Apr. 30, 2020
Applicants:

Shanghai Haiyan Pharmaceutical Technology Co., Ltd., Shanghai, CN;

Yangtze River Pharmaceutical Group Co., Ltd., Taizhou, CN;

Inventors:

Songliang Wu, Shanghai, CN;

Zhi Luo, Shanghai, CN;

Yuan Chen, Shanghai, CN;

Yuhe Wang, Shanghai, CN;

Dakun Qin, Shanghai, CN;

Xiaolin Li, Shanghai, CN;

Zheng Wang, Shanghai, CN;

Weidong Li, Shanghai, CN;

Haiying He, Shanghai, CN;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 451/02 (2006.01); A61K 31/506 (2006.01); A61K 31/46 (2006.01); A61P 25/34 (2006.01); A61P 25/20 (2006.01); A61P 25/22 (2006.01); A61P 11/08 (2006.01);
U.S. Cl.
CPC ...
A61K 31/506 (2013.01); A61K 31/46 (2013.01); A61P 11/08 (2018.01); A61P 25/20 (2018.01); A61P 25/22 (2018.01); A61P 25/34 (2018.01); C07D 451/02 (2013.01);
Abstract

Disclosed is a preparation method of an orexin receptor antagonist compound 5-3. Crystalline forms I-IV of an orexin receptor antagonist compound 5-3 are provided. Also provided are processes of preparing crystalline forms of the orexin receptor antagonist compound 5-3, as well as methods of using the crystalline forms I-IV for treating an orexin-related disease.


Find Patent Forward Citations

Loading…